Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis
Open Access
- 28 June 2023
- journal article
- review article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 18 (6) , e0286887
Abstract
Background: Aberrant brain insulin signaling has been posited to lie at the crossroads of several metabolic and cognitive disorders. Intranasal insulin (INI) is a non-invasive approach that allows investigation and modulation of insulin signaling in the brain while limiting peripheral side effects. Objectives: The objective of this systematic review and meta-analysis is to evaluate the effects of INI on cognition in diverse patient populations and healthy individuals. Methods: MEDLINE, EMBASE, PsycINFO, and Cochrane CENTRAL were systematically searched from 2000 to July 2021. Eligible studies were randomized controlled trials that studied the effects of INI on cognition. Two independent reviewers determined study eligibility and extracted relevant descriptive and outcome data. Results: Twenty-nine studies (pooled N = 1,726) in healthy individuals as well as those with Alzheimer’s disease (AD)/mild cognitive impairment (MCI), mental health disorders, metabolic disorders, among others, were included in the quantitative meta-analysis. Patients with AD/MCI treated with INI were more likely to show an improvement in global cognition (SMD = 0.22, 95% CI: 0.05–0.38 p = N = 12 studies). Among studies with healthy individuals and other patient populations, no significant effects of INI were found for global cognition. Conclusions: This review demonstrates that INI may be associated with pro-cognitive benefits for global cognition, specifically for individuals with AD/MCI. Further studies are required to better understand the neurobiological mechanisms and differences in etiology to dissect the intrinsic and extrinsic factors contributing to the treatment response of INI.Keywords
This publication has 55 references indexed in Scilit:
- Intranasal Insulin Therapy for Alzheimer Disease and Amnestic Mild Cognitive ImpairmentArchives of Neurology, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- No Effect of Single-Dose Intranasal Insulin Treatment on Verbal Memory and Sustained Attention in Patients With SchizophreniaJournal of Clinical Psychopharmacology, 2011
- Synaptic Mechanisms for Plasticity in NeocortexAnnual Review of Neuroscience, 2009
- Intranasal insulin improves cognition and modulates β-amyloid in early ADNeurology, 2008
- Obese men respond to cognitive but not to catabolic brain insulin signalingInternational Journal of Obesity, 2007
- Intranasal Insulin Improves Memory in Humans: Superiority of Insulin AspartNeuropsychopharmacology, 2006
- Intranasal insulin improves memory in humansPsychoneuroendocrinology, 2004
- Quantifying heterogeneity in a meta‐analysisStatistics in Medicine, 2002
- Insulin receptors are widely distributed in human brain and bind human and porcine insulin with equal affinityDiabetic Medicine, 1997